This report provides an assessment of state and territory performance against the performance benchmarks outlined in the National Partnership on Essential Vaccines, for the assessment period 1 April 2021 to 31 March 2022.

This white paper analyses the current state of chimeric antigen receptor (CAR) T-cell therapy in Australia, expected opportunities and our healthcare system’s preparedness for delivering CAR T-cell therapy at scale.

A national long COVID and COVID-19 database is among the key recommendations in this report. Overall, the Committee makes nine recommendations aimed at strengthening the Australian government’s management of long COVID.

This paper examines the role of research that seeks to obtain evidence to support evidence-based medicine (EBM), using a case study of research into ear disease in Aboriginal populations, and suggested that in complex situations, perhaps randomised controlled trials are not the answer.

In 2018, a Parliamentary Joint Committee recommended an urgent ban be implemented on the use of predictive genetic test results in life insurance underwriting in Australia. This article evaluates whether the moratorium meets the Parliamentary Committee recommendations, and finds that it falls short in key areas, requiring further regulation by the Australian government.